Bromocriptine, an ergot alkaloid, inhibits excitatory amino acid release mediated by glutamate transporter reversal

European Journal of Pharmacology

Volumn 643, Issue 1, 2010, Pages 48-57

  Shirasaki, Yasufumi ^a   Sugimura, Masunobu ^a   Sato, Toshiyuki ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

Bromocriptine; EAAT2; GLT 1; Glutamate transporter; Ischemia

Indexed keywords

ASPARTIC ACID; BROMOCRIPTINE; DIHYDROKAINIC ACID; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMIC ACID; POTASSIUM CHLORIDE; SODIUM ION; SULPIRIDE;

AMINO ACID BRAIN LEVEL; AMINO ACID TRANSPORT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOXIA; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; CELL STRAIN HEK293; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; EXTRACELLULAR SPACE; FOREBRAIN; GERBIL; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 77955054223     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.06.007     Document Type: Article

References (61)

1. Abdullaev I.F., Rudkouskaya A., Schools G.P., Kimelberg H.K., Mongin A.A. Pharmacological comparison of swelling-activated excitatory amino acid release and Cl- currents in cultured rat astrocytes. J. Physiol. 2006, 572:677-689.
2. Anderson C.M., Bridges R.J., Chamberlin A.R., Shimamoto K., Yasuda-Kamatani Y., Swanson R.A. Differing effects of substrate and non-substrate transport inhibitors on glutamate uptake reversal. J. Neurochem. 2001, 79:1207-1216.
3. Arriza J.L., Eliasof S., Kavanaugh M.P., Amara S.G. Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:4155-4160.
4. Barbour B., Magnus C., Szatkowski M., Gray P.T., Attwell D. Changes in NAD(P)H fluorescence and membrane current produced by glutamate uptake into salamander Muller cells. J. Physiol. 1993, 466:573-597.
5. Bonde C., Sarup A., Schousboe A., Gegelashvili G., Noraberg J., Zimmer J. GDNF pre-treatment aggravates neuronal cell loss in oxygen-glucose deprived hippocampal slice cultures: a possible effect of glutamate transporter up-regulation. Neurochem. Int. 2003, 43:381-388.
6. Bonde C., Sarup A., Schousboe A., Gegelashvili G., Zimmer J., Noraberg J. Neurotoxic and neuroprotective effects of the glutamate transporter inhibitor dl-threo-beta-benzyloxyaspartate (DL-TBOA) during physiological and ischemia-like conditions. Neurochem. Int. 2003, 43:371-380.
7. Chen Y., Swanson R.A. Astrocytes and brain injury. J. Cereb. Blood Flow Metab. 2003, 23:137-149.
8. Choi D.W. Ionic dependence of glutamate neurotoxicity. J. Neurosci. 1987, 7:369-379.
9. Colleoni S., Jensen A.A., Landucci E., Fumagalli E., Conti P., Pinto A., De Amici M., Pellegrini-Giampietro D.E., De Micheli C., Mennini T., Gobbi M. Neuroprotective effects of the novel glutamate transporter inhibitor (-)-3-hydroxy-4, 5, 6, 6a-tetrahydro-3aH-pyrrolo[3, 4-d]-isoxazole-4-carboxylic acid, which preferentially inhibits reverse transport (glutamate release) compared with glutamate reuptake. J. Pharmacol. Exp. Ther. 2008, 326:646-656.
10. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65:1-105.
11. Dronne M.A., Grenier E., Dumont T., Hommel M., Boissel J.P. Role of astrocytes in grey matter during stroke: a modelling approach. Brain Res. 2007, 1138:231-242.
12. Duan S., Anderson C.M., Keung E.C., Chen Y., Swanson R.A. P2X7 receptor-mediated release of excitatory amino acids from astrocytes. J. Neurosci. 2003, 23:1320-1328.
13. Fairman W.A., Vandenberg R.J., Arriza J.L., Kavanaugh M.P., Amara S.G. An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 1995, 375:599-603.
14. Furuta A., Martin L.J., Lin C.L., Dykes-Hoberg M., Rothstein J.D. Cellular and synaptic localization of the neuronal glutamate transporters excitatory amino acid transporter 3 and 4. Neuroscience 1997, 81:1031-1042.
15. +-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotection. Neurobiol. Dis. 2006, 21:556-567.
16. Guo H., Lai L., Butchbach M.E., Stockinger M.P., Shan X., Bishop G.A., Lin C.L. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice. Hum. Mol. Genet. 2003, 12:2519-2532.
17. Hamann M., Rossi D.J., Marie H., Attwell D. Knocking out the glial glutamate transporter GLT-1 reduces glutamate uptake but does not affect hippocampal glutamate dynamics in early simulated ischaemia. Eur. J. Neurosci. 2002, 15:308-314.
18. Haugeto O., Ullensvang K., Levy L.M., Chaudhry F.A., Honore T., Nielsen M., Lehre K.P., Danbolt N.C. Brain glutamate transporter proteins form homomultimers. J. Biol. Chem. 1996, 271:27715-27722.
19. Hazell A.S. Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies. Neurochem. Int. 2007, 50:941-953.
20. Kanai Y., Hediger M.A. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 1992, 360:467-471.
21. Kartzinel R., Teychenne P., Gillespie M.M., Perlow M., Gielen A.C., Sadowsky D.A., Calne D.B. Bromocriptine and levodopa (with or without carbidopa) in parkinsonism. Lancet 1976, 2:272-275.
22. 2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade. J. Neurosci. Res. 2002, 70:274-282.
23. Kimelberg H.K. Astrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy. Glia 2005, 50:389-397.
24. Kosugi T., Kawahara K., Yamada T., Nakajima T., Tanaka M. Functional significance of the preconditioning-induced down-regulation of glutamate transporter GLT-1 in neuron/astrocyte co-cultures. Neurochem. Res. 2005, 30:1109-1116.
25. Lehre K.P., Levy L.M., Ottersen O.P., Storm-Mathisen J., Danbolt N.C. Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J. Neurosci. 1995, 15:1835-1853.
26. Liu X.H., Kato H., Chen T., Kato K., Itoyama Y. Bromocriptine protects against delayed neuronal death of hippocampal neurons following cerebral ischemia in the gerbil. J. Neurol. Sci. 1995, 129:9-14.
27. Longuemare M.C., Swanson R.A. Excitatory amino acid release from astrocytes during energy failure by reversal of sodium-dependent uptake. J. Neurosci. Res. 1995, 40:379-386.
28. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Dopamine receptors: from structure to function. Physiol. Rev. 1998, 78:189-225.
29. Mitani A., Tanaka K. Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. J. Neurosci. 2003, 23:7176-7182.
30. Nilius B., Droogmans G. Amazing chloride channels: an overview. Acta Physiol. Scand. 2003, 177:119-147.
31. 2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia. Eur. J. Pharmacol. 1998, 352:37-46.
32. Phillis J.W., Ren J., O'Regan M.H. Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studies with dl-threo-beta-benzyloxyaspartate. Brain Res. 2000, 868:105-112.
33. Pines G., Danbolt N.C., Bjoras M., Zhang Y., Bendahan A., Eide L., Koepsell H., Storm-Mathisen J., Seeberg E., Kanner B.I. Cloning and expression of a rat brain l-glutamate transporter. Nature 1992, 360:464-467.
34. Robinson M.B. The family of sodium-dependent glutamate transporters: a focus on the GLT-1/EAAT2 subtype. Neurochem. Int. 1998, 33:479-491.
35. Rothstein J.D., Martin L., Levey A.I., Dykes-Hoberg M., Jin L., Wu D., Nash N., Kuncl R.W. Localization of neuronal and glial glutamate transporters. Neuron 1994, 13:713-725.
36. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996, 16:675-686.
37. Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., Jin L., Dykes Hoberg M., Vidensky S., Chung D.S., Toan S.V., Bruijn L.I., Su Z.Z., Gupta P., Fisher P.B. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005, 433:73-77.
38. Satoh M., Asai S., Katayama Y., Kohno T., Ishikawa K. Real-time monitoring of glutamate transmitter release with anoxic depolarization during anoxic insult in rat striatum. Brain Res. 1999, 822:142-148.
39. 2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress. Ann. Neurol. 1998, 44:110-119.
40. +-dependent glutamate transporters by cyclic AMP analogs and neurons. Mol. Pharmacol. 1998, 53:355-369.
41. Seal R.P., Amara S.G. Excitatory amino acid transporters: a family in flux. Annu. Rev. Pharmacol. Toxicol. 1999, 39:431-456.
42. Seki Y., Feustel P.J., Keller R.W., Tranmer B.I., Kimelberg H.K. Inhibition of ischemia-induced glutamate release in rat striatum by dihydrokinate and an anion channel blocker. Stroke 1999, 30:433-440.
43. Selkirk J.V., Nottebaum L.M., Vana A.M., Verge G.M., Mackay K.B., Stiefel T.H., Naeve G.S., Pomeroy J.E., Petroski R.E., Moyer J., Dunlop J., Foster A.C. Role of the GLT-1 subtype of glutamate transporter in glutamate homeostasis: the GLT-1-preferring inhibitor WAY-855 produces marginal neurotoxicity in the rat hippocampus. Eur. J. Neurosci. 2005, 21:3217-3228.
44. Selkirk J.V., Stiefel T.H., Stone I.M., Naeve G.S., Foster A.C., Poulsen D.J. Over-expression of the human EAAT2 glutamate transporter within neurons of mouse organotypic hippocampal slice cultures leads to increased vulnerability of CA1 pyramidal cells. Eur. J. Neurosci. 2005, 21:2291-2296.
45. Sheldon A.L., Robinson M.B. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem. Int. 2007, 51:333-355.
46. Shigeri Y., Seal R.P., Shimamoto K. Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res. Rev. 2004, 45:250-265.
47. Shirasaki Y., Kanazawa Y., Morishima Y., Makino M. Involvement of calmodulin in neuronal cell death. Brain Res. 2006, 1083:189-195.
48. Sims K.D., Robinson M.B. Expression patterns and regulation of glutamate transporters in the developing and adult nervous system. Crit. Rev. Neurobiol. 1999, 13:169-197.
49. Storck T., Schulte S., Hofmann K., Stoffel W. Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:10955-10959.
50. Swanson R.A., Liu J., Miller J.W., Rothstein J.D., Farrell K., Stein B.A., Longuemare M.C. Neuronal regulation of glutamate transporter subtype expression in astrocytes. J. Neurosci. 1997, 17:932-940.
51. Szatkowski M., Barbour B., Attwell D. Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature 1990, 348:443-446.
52. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., Okuyama S., Kawashima N., Hori S., Takimoto M., Wada K. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997, 276:1699-1702.
53. Tetsuka K., Hosoya K.I., Ohtsuki S., Takanaga H., Yanai N., Ueda M., Obinata M., Terasaki T. Acidic amino acid transport characteristics of a newly developed conditionally immortalized rat type 2 astrocyte cell line (TR-AST). Cell Struct. Funct. 2001, 26:197-203.
54. Wisman L.A., van Muiswinkel F.L., de Graan P.N., Hol E.M., Bar P.R. Cells over-expressing EAAT2 protect motoneurons from excitotoxic death in vitro. NeuroReport 2003, 14:1967-1970.
55. Yamashita H., Kawakami H., Zhang Y.X., Hagiwara T., Tanaka K., Nakamura S. Inhibition by folded isomers of L-2-(carboxycyclopropyl)glycine of glutamate uptake via the human glutamate transporter hGluT-1. Eur. J. Pharmacol. 1995, 289:387-390.
56. Yamashita H., Kawakami H., Zhang Y.X., Tanaka K., Nakamura S. Effect of amino acid ergot alkaloids on glutamate transport via human glutamate transporter hGluT-1. J. Neurol. Sci. 1998, 155:31-36.
57. Ye Z.C., Wyeth M.S., Baltan-Tekkok S., Ransom B.R. Functional hemichannels in astrocytes: a novel mechanism of glutamate release. J. Neurosci. 2003, 23:3588-3596.
58. Yi J.H., Hazell A.S. Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury. Neurochem. Int. 2006, 48:394-403.
59. Yoshikawa T., Minamiyama Y., Naito Y., Kondo M. Antioxidant properties of bromocriptine, a dopamine agonist. J. Neurochem. 1994, 62:1034-1038.
60. Zelenaia O., Schlag B.D., Gochenauer G.E., Ganel R., Song W., Beesley J.S., Grinspan J.B., Rothstein J.D., Robinson M.B. Epidermal growth factor receptor agonists increase expression of glutamate transporter GLT-1 in astrocytes through pathways dependent on phosphatidylinositol 3-kinase and transcription factor NF-kappaB. Mol. Pharmacol. 2000, 57:667-678.
61. Zhang Y., Zhang H., Feustel P.J., Kimelberg H.K. DCPIB, a specific inhibitor of volume regulated anion channels (VRACs), reduces infarct size in MCAo and the release of glutamate in the ischemic cortical penumbra. Exp. Neurol. 2008, 210:514-520.